The French Data Protection Agency (CNIL) has been actively supporting digital health technology innovators through its regulatory “sandbox.” These projects range from federated learning across health data warehouses to building diagnostic tools in oncology, statistical indicators for medical research, and a therapeutic game for minors with eating disorders. The CNIL provides crucial guidance on overcoming regulatory challenges, including the nature of data, legal frameworks, and data security measures.
Benefits for RWD, RWE, and Digital Health Innovators:
- Navigating Regulatory Challenges: The CNIL’s sandbox provides a safe environment to test solutions and understand regulations. For RWD and RWE developers, this means an easier path to compliance with GDPR and other privacy laws.
- Interconnected Data Sources: For projects like Resilience in oncology, CNIL’s guidance enabled the interconnection of various data sources. This has implications for RWD, as it becomes easier to integrate data from disparate sources for more comprehensive Real-World Evidence.
- Data Security: With its focus on secure data processing, the sandbox offers a blueprint for ensuring the safety of health data, which is invaluable for digital health innovators dealing with sensitive patient information.
- AI and Machine Learning: Projects like the one carried out at Lille University Hospital utilized federated learning protocols, offering a roadmap for implementing machine learning algorithms in healthcare. This aids RWD and RWE applications where machine learning could provide new insights.
- Specialized Use-Cases: The Vertexica project focusing on minors with eating disorders shows how data protection can be maintained even in specialized healthcare solutions, thereby ensuring the ethical use of Real-World Data.
- Knowledge Sharing: The joint work and multiple exchanges with CNIL have generated lessons that could be useful for the broader health sector, facilitating faster and more secure innovation.
- ‘Privacy by Design’: The emphasis on integrating GDPR compliance from the design phase benefits all stakeholders by baking in data protection from the outset, which is a fundamental need in RWD and RWE applications.
- Stakeholder Collaboration: The sandbox projects involve multi-disciplinary teams, demonstrating a collaborative approach that could benefit digital health innovators, RWD and RWE developers in addressing complex regulatory and ethical issues.
In essence, the CNIL’s regulatory sandbox serves as an invaluable resource, not just as a testing ground but as a knowledge base for RWD, RWE, and digital health innovators. It provides practical insights into overcoming regulatory challenges and implementing secure, effective healthcare solutions.
Share this story...
Real World Evidence (RWE) 201 – France – CNIL Regulatory Sandbox: Digital Health
RWE 201 - France – CNIL Regulatory Sandbox: Digital Health The French Data Protection Agency (CNIL) has been actively supporting digital health technology innovators through its regulatory "sandbox." These [...]
Real World Evidence (RWE) 201 – France – CNIL Reference Methodologies: Facilitating Access to Real World Data
RWE 201 - France – CNIL Reference Methodologies: Facilitating Access to Real World Data The CNIL (Commission Nationale de l'Informatique et des Libertés) is the French [...]
Real World Evidence (RWE) 201 – France – Health Data Hub: Facilitating Access to Real World Data
RWE 201 - France – Health Data Hub: Facilitating Access to Real World Data The purpose of France's Health Data Hub (HDH) is to facilitate the [...]
Real World Evidence (RWE) 201 – Canada – Health Canada’s position on the CADTH Guidance for Reporting RWE to Support Decision-making
RWE 201 - Canada – Health Canada’s position on the CADTH Guidance for Reporting RWE to Support Decision-making Health Canada released its position (May 2023) on [...]
Real World Evidence (RWE) 201 – Canada – Methods and Guidelines for Reporting Real World Evidence
RWE 201 - Canada – Methods and Guidelines for Reporting Real World Evidence Guidance for Reporting Real-World Evidence (RWE) [published May 2023] is a comprehensive document developed by the [...]
Real World Evidence (RWE) 201 – Health Canada’s 15 Key Elements for Protocol Development
RWE 201 - Health Canada's 15 Key Elements for Protocol Development Health Canada acknowledges that RWE can be particularly useful in areas where conducting controlled clinical trials is challenging [...]







